Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP4 | P15090 | 8/20 | 0.44 |
| ▸ | FABP3 | P05413 | 7/20 | 0.44 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.44 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.38 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | MAP2 | P11137 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | GUSB | P08236 | 1/20 | 0.34 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL308199 | 0.79 | CYP2A6 (0.55) | FABP4FABP3FABP5CYP2A6PTGS1 | |
| SCHEMBL5359524 | 0.79 | CYP2A6 (0.41) | CYP2A6PTGS1PTGS2RAB9ALMNA | |
| SCHEMBL1225074 | 0.74 | TSHR (0.50) | CYP2A6RAB9ALMNATSHRCYP1A2 | |
| SCHEMBL4270859 | 0.71 | CYP2A6 (0.65) | FABP4FABP3FABP5CYP2A6PTGS1 | |
| SCHEMBL27715394 | 0.71 | TSHR (0.56) | FABP4FABP3FABP5CYP2A6LMNA | |
| SCHEMBL2103502 | 0.70 | TSHR (0.44) | CYP2A6LMNATSHRCYP1A2MEN1 | |
| SCHEMBL11454164 | 0.70 | MAPK1 (0.44) | FABP4FABP3FABP5CYP2A6PTGS1 | |
| SCHEMBL28638926 | 0.70 | CYP2A6 (0.44) | FABP4FABP3FABP5CYP2A6PTGS1 | |
| SCHEMBL28364118 | 0.70 | CYP2A6 (0.44) | FABP4FABP3FABP5CYP2A6PTGS1 | |
| SCHEMBL20108554 | 0.70 | FABP4 (0.53) | FABP4FABP3FABP5CYP2A6PTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0763001-B1 | SELECTIVE PRODUCTION OF PARA-DIALKYL SUBSTITUTED BENZENES | MOBIL OIL CORP (US) | 1999-09-08 | — | — | EP | claimed |
| EP-0128721-B1 | SILICA-MODIFIED CATALYST AND USE FOR SELECTIVE PRODUCTION OF PARA-DIALKYL SUBSTITUTED BENZENES | MOBIL OIL CORPORATION (US) | 1989-07-26 | — | — | EP | claimed |
| US-6541408-B2 | Progressive temperature gradient stabilizes hydrorefining catalysts (metal-modified zeolite) to allow long duration of use and low by-product make | EXXONMOBIL OIL CORP. | 2003-04-01 | — | — | US | disclosed |
| US-20020091293-A1 | Zeolite catalysts having stabilized hydrogenation-dehydrogenation function | EXXONMOBIL OIL CORPORATION | 2002-07-11 | — | — | US | disclosed |
| US-6346498-B1 | PERMEATING METAL INTO MOLECULAR SIEVE; IN SITU SELECTIVATION WITH SILICON COMPOUND AND ROASTING; BY-PRODUCT INHIBITION | EXXONMOBIL OIL CORPORATION | 2002-02-12 | — | — | US | disclosed |
| US-6207871-B1 | CONVERTING A HYDROCARBON FEEDSTREAM COMPRISING ETHYLBENZENE AND META-XYLENE OVER MOLECULAR SIEVE CATALYST UNDER ETHYLBENZENE CONVERSION CONDITIONS, | MOBIL OIL CORPORATION | 2001-03-27 | — | — | US | disclosed |
| US-4532368-A | Passing mixture of phenol, ortho-alkylphenol, alkylating agent through zeolite catalyst, separating and recycling ortho-alkylphenols | ETHYL CORPORATION (US) | 1985-07-30 | — | — | US | disclosed |
| US-4444989-A | Methylation of toluene to para-xylene catalyzed by crystalline silica | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1984-04-24 | — | — | US | disclosed |
| US-4283306-A | CATALYTIC METHYLATION OF TOLUENE | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1981-08-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020091293-A1 | Zeolite catalysts having stabilized hydrogenation-dehydrogenation function | HDHD5, HSF1, HRH4 | FABP4 1941/4885FABP3 2782/4885FABP5 2164/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.